The PE ratio for Chemed stock stands at 29.78 as of Mar 11, 2025. The calculation is based on the latest EPS of $20.1 and the stock price of $598.5 per share. The PE ratio currently is comparable to its last four-quarter average.
Over the last ten years, the average PE ratio of Chemed has been 28.42. The current 29.78 P/E ratio is 4.8% higher than the historical average. Looking back at the last ten years, CHE's PE ratio peaked in the Jun 2017 quarter at 49.52, with a price of $204.53 and an EPS of $4.13. The Mar 2015 quarter marked the lowest point at 19.7, with a price of $119.4 and an EPS of $6.06.
Maximum annual increase: 64.61% in 2017
Maximum annual decrease: -44.36% in 2018
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 26.36 | -18.36% | $529.8 | $20.1 |
2023 | 32.29 | 5.76% | $584.75 | $18.11 |
2022 | 30.53 | -1.1% | $510.43 | $16.72 |
2021 | 30.87 | 16.05% | $529.04 | $17.14 |
2020 | 26.6 | -16.61% | $532.61 | $20.02 |
2019 | 31.9 | 44.15% | $439.26 | $13.77 |
2018 | 22.13 | -44.36% | $283.28 | $12.8 |
2017 | 39.77 | 64.61% | $243.02 | $6.11 |
2016 | 24.16 | 5.46% | $160.41 | $6.64 |
2015 | 22.91 | 25.53% | $149.8 | $6.54 |
2014 | 18.25 | 1% | $105.67 | $5.79 |
2013 | 18.07 | 24.36% | $76.62 | $4.24 |
2012 | 14.53 | 18.9% | $68.59 | $4.72 |
2011 | 12.22 | -30.33% | $51.21 | $4.19 |
2010 | 17.54 | 20.3% | $63.51 | $3.62 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | 26.36 | -12.22% | $529.8 | $20.1 |
Sep 2024 | 30.03 | 10.36% | $600.97 | $20.01 |
Jun 2024 | 27.21 | -20.39% | $542.58 | $19.94 |
Mar 2024 | 34.18 | 5.85% | $641.93 | $18.78 |
Dec 2023 | 32.29 | 1.29% | $584.75 | $18.11 |
Sep 2023 | 31.88 | -10.83% | $519.7 | $16.3 |
Jun 2023 | 35.75 | 6.78% | $541.67 | $15.15 |
Mar 2023 | 33.48 | 9.66% | $537.75 | $16.06 |
Dec 2022 | 30.53 | 21.83% | $510.43 | $16.72 |
Sep 2022 | 25.06 | -2.72% | $436.56 | $17.42 |
Jun 2022 | 25.76 | -11.81% | $469.39 | $18.22 |
Mar 2022 | 29.21 | -5.38% | $506.55 | $17.34 |
Dec 2021 | 30.87 | 28.68% | $529.04 | $17.14 |
Sep 2021 | 23.99 | -3.85% | $465.12 | $19.39 |
Jun 2021 | 24.95 | 11.83% | $474.5 | $19.02 |
CHE's current PE ratio is higher than the 5 and 10-year averages, but it is lower than its 3-year average.
In comparison to its peers BCPC and AMED, CHE's PE ratio is lower, but it is higher than RPM's and SXT's. Chemed is currently trading at a lower PE ratio (29.78) than its peers average of 40.13.
Stock name | PE ratio | Market cap |
---|---|---|
RPM Rpm International Inc | 23.03 | $15.07B |
SXT Sensient Technologies Corp | 24.97 | $3.13B |
CHE Chemed Corp | 29.49 | $8.68B |
BCPC Balchem Corp | 42.53 | $5.49B |
AMED Amedisys Inc | 69.77 | $3.53B |
As of Mar 11, 2025, CHE stock has a price to earnings ratio of 29.78.
As an average over the last 3 years, CHE stock has a PE ratio of 30.15.
As an average over the last 5 years, CHE stock has a PE ratio of 28.81.
Over the last ten years, the quarterly PE ratio reached its highest level at 49.52 in the Jun 2017 quarter.
CHE's current price to earnings ratio is 4.8% above its 10-year historical average.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Mar 11, 2025), Chemed's share price is $598.5. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $20.1. Therefore, Chemed's PE ratio for today is 29.78. PE RATIO(29.78) = STOCK PRICE($598.5) / TTM EPS($20.1)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.